X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
1. Apocard
2. Flcane
3. Flecadura
4. Flecainid Isis
5. Flecainid-isis
6. Flecainide
7. Flecainide Monoacetate
8. Flecainide Monoacetate, (+-)-isomer
9. Flecainide Monoacetate, (r)-isomer
10. Flecainide Monoacetate, (s)-isomer
11. Flecainide, (r)-isomer
12. Flecainide, (s)-isomer
13. Flecainide, 5-ho-n-(6-oxo)-derivative
14. Flecainide, 5-ho-n-(6-oxo)-derivative, (+-)-isomer
15. Flecatab
16. R818
17. Tambocor
1. 54143-56-5
2. Flecainide (acetate)
3. Tambocor
4. R-818
5. Flecainide Monoacetate
6. Flecainide Acetate Salt
7. R 818
8. 54143-56-5 (acetate)
9. N-(2-piperidylmethyl)-2,5-bis-(2,2,2-trifluoroethoxy)benzamide Acetate
10. N-(piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide Monoacetate
11. Mls000069675
12. Chebi:5091
13. M8u465q1wq
14. Apocard
15. Benzamide, N-(2-piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)-, Monoacetate
16. Benzamide, N-(2-piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)-,monoacetate
17. N-(2-piperidylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide Monoacetate
18. Smr000058451
19. Acetic Acid;n-(piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide
20. N-(piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide Acetate
21. Sr-01000000172
22. Einecs 258-997-5
23. Mfcd00214290
24. Unii-m8u465q1wq
25. Flecainidacetat
26. Tambocor (tn)
27. Flecainide Acetate [usan:usp:jan]
28. N-(2-piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide Monoacetate
29. Dsstox_cid_626
30. Opera_id_1587
31. 2,5-bis-(2,2,2-trifluoroethoxy)-n-(2-piperidinylmethyl)benzamide Acetate
32. Cas-54143-56-5
33. Dsstox_rid_75700
34. Dsstox_gsid_20626
35. Mls001148177
36. Mls002222300
37. Schembl121583
38. Chembl1200822
39. Dtxsid8020626
40. Flecainide Acetate [jan]
41. Flecainide Acetate (jp17/usp)
42. Flecainide For System Suitability
43. Flecainide Acetate [usan]
44. Flecainide Acetate [vandf]
45. Hms1570c12
46. Hms2097c12
47. Hms2231e15
48. Hms3259f11
49. Hms3267n04
50. Hms3369m07
51. Hms3412d09
52. Hms3676d09
53. Hms3714c12
54. Flecainide Acetate [mart.]
55. 11a-hydroxyepoxyprogesterone
56. Bcp17825
57. Flecainide Acetate [usp-rs]
58. Flecainide Acetate [who-dd]
59. Tox21_200208
60. Akos015889993
61. N-(piperidin-2-ylmethyl)-2,5-bis[(2,2,2-trifluoroethyl)oxy]benzamide Acetate
62. Ccg-220735
63. Cs-1400
64. Nc00641
65. Sb19142
66. Flecainide Acetate [ep Impurity]
67. Flecainide Acetate [orange Book]
68. Flecainide Acetate [ep Monograph]
69. Flecainide Acetate [usp Impurity]
70. Ncgc00093934-01
71. Ncgc00093934-02
72. Ncgc00257762-01
73. As-11702
74. Flecainide Acetate [usp Monograph]
75. Hy-17429
76. Db-052497
77. Eu-0100546
78. Ft-0630667
79. En300-51344
80. D00638
81. E-0735
82. F 6777
83. 143f565
84. Sr-01000000172-2
85. Sr-01000000172-4
86. Sr-01000000172-5
87. Sr-01000000172-7
88. Q27089351
89. Flecainide Acetate, British Pharmacopoeia (bp) Reference Standard
90. Flecainide Acetate, European Pharmacopoeia (ep) Reference Standard
91. 2,5-bis(2,2,2-trifluoroethoxy)-n-(2-piperidylmethyl)benzamide Acetate
92. Flecainide Acetate, United States Pharmacopeia (usp) Reference Standard
93. 2-({[2,5-bis(2,2,2-trifluoroethoxy)benzoyl]amino}methyl)piperidinium Acetate
94. Flecainide For System Suitability, European Pharmacopoeia (ep) Reference Standard
| Molecular Weight | 474.4 g/mol |
|---|---|
| Molecular Formula | C19H24F6N2O5 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 7 |
| Exact Mass | 474.15894084 g/mol |
| Monoisotopic Mass | 474.15894084 g/mol |
| Topological Polar Surface Area | 96.9 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 531 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 2 | |
|---|---|
| Drug Name | Flecainide acetate |
| Drug Label | Flecainide acetate is an antiarrhythmic drug available in tablets of 50, 100, or 150 mg for oral administration. Flecainide acetate is benzamide, N-(2-piperidinylmethyl)-2,5-bis (2,2,2-trifluoroethoxy)-monoacetate. Its molecular formula is C17H20F6N2... |
| Active Ingredient | Flecainide acetate |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 100mg; 50mg; 150mg |
| Market Status | Prescription |
| Company | Ranbaxy; Amneal Pharm; Roxane; Barr |
| 2 of 2 | |
|---|---|
| Drug Name | Flecainide acetate |
| Drug Label | Flecainide acetate is an antiarrhythmic drug available in tablets of 50, 100, or 150 mg for oral administration. Flecainide acetate is benzamide, N-(2-piperidinylmethyl)-2,5-bis (2,2,2-trifluoroethoxy)-monoacetate. Its molecular formula is C17H20F6N2... |
| Active Ingredient | Flecainide acetate |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 100mg; 50mg; 150mg |
| Market Status | Prescription |
| Company | Ranbaxy; Amneal Pharm; Roxane; Barr |
Anti-Arrhythmia Agents
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)
Voltage-Gated Sodium Channel Blockers
A class of drugs that inhibit the activation of VOLTAGE-GATED SODIUM CHANNELS. (See all compounds classified as Voltage-Gated Sodium Channel Blockers.)
Market Place
